Back
Biogen 10K Form
Sell
48
BIIB
Biogen
Last Price:
$123.49
Seasonality Move:
8.34%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BIIB News And Ratings
See the #1 stock for the next 7 days that we like better than BIIB
BIIB Financial Statistics
Sales & Book Value
| Annual Sales: | $9.7B |
|---|---|
| Cash Flow: | $212.2M |
| Price / Cash Flow: | 7.86 |
| Annual Sales: | $115.90 |
| Price / Book: | 1.07 |
Profitability
| EPS (TTM): | 10.13000 |
|---|---|
| Net Income (TTM): | $1.5B |
| Gross Margin: | $7.4B |
| Return on Equity: | 9.11% |
| Return on Assets: | 5.37% |
Biogen Earnings Forecast
Key Biogen Financial Ratios
-
The Gross Profit Margin over the past 41 years for BIIB is 76.12%.
-
The Selling, General & Administrative Expenses for BIIB have been equal to 24.84% of Gross Profit Margin.
-
The Research & Development expenses have been 21.10% of Revenue.
-
The Interest Expense is 15.34% of Operating Income.
-
The Net Earning history of BIIB is 16.87% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 30 years.
Biogen Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BIIB |
| CUSIP: | 09062X |
| Website: | biogen.com |
Debt
| Debt-to-Equity Ratio: | 0.37 |
|---|---|
| Current Ratio: | 1.44 |
| Quick Ratio: | 0.87 |
Price-to-Earnings
| Trailing P/E Ratio: | 11.05 |
|---|---|
| Forward P/E Ratio: | 8.01 |